0KF3 Relative Valuation - Palatin Technologies Inc - Alpha Spread
P

Palatin Technologies Inc
LSE:0KF3

Watchlist Manager
Palatin Technologies Inc
LSE:0KF3
Watchlist
Price: 1.46 USD -0.75% Market Closed
Market Cap: 40.1B USD
Have any thoughts about
Palatin Technologies Inc?
Write Note

Relative Value

The Relative Value of one 0KF3 stock under the Base Case scenario is 0.13 USD. Compared to the current market price of 1.46 USD, Palatin Technologies Inc is Overvalued by 91%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

0KF3 Relative Value
Base Case
0.13 USD
Overvaluation 91%
Relative Value
Price
P
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
57
vs Industry
14
Median 3Y
12 139.5
Median 5Y
8 498.8
Industry
7.7
Forward
9 622
vs History
vs Industry
Median 3Y
-1 566.4
Median 5Y
-665.9
Industry
23.9
Forward
-1 217.9
vs History
vs Industry
Median 3Y
-1 488.6
Median 5Y
-1 189.9
Industry
22.2
vs History
vs Industry
Median 3Y
-1 480
Median 5Y
-964.9
Industry
24
vs History
14
vs Industry
1
Median 3Y
3 791.7
Median 5Y
313.9
Industry
2.5
vs History
57
vs Industry
11
Median 3Y
12 137.2
Median 5Y
8 497.4
Industry
7.4
Forward
9 619.6
vs History
53
vs Industry
8
Median 3Y
14 169
Median 5Y
8 158.3
Industry
8.5
vs History
vs Industry
Median 3Y
-1 574.8
Median 5Y
-614.6
Industry
5.1
Forward
-923.2
vs History
vs Industry
Median 3Y
-1 558.6
Median 5Y
-613
Industry
4.7
Forward
-1 322.4
vs History
vs Industry
Median 3Y
-1 488.3
Median 5Y
-1 186.2
Industry
6.6
vs History
vs Industry
Median 3Y
-1 484.5
Median 5Y
-1 186.2
Industry
4.7
vs History
vs Industry
2
Median 3Y
3 479.1
Median 5Y
2 679.4
Industry
4.7

Multiples Across Competitors

0KF3 Competitors Multiples
Palatin Technologies Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Palatin Technologies Inc
LSE:0KF3
40.1B USD 6 792.6 -1 219.7 -1 236.1 -1 223.4
US
Abbvie Inc
NYSE:ABBV
344.8B USD 6.3 65.1 15.9 24.3
US
Amgen Inc
NASDAQ:AMGN
180B USD 5.8 57.5 20.1 36.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
128.6B USD 9.5 29.7 26.1 28.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126B USD 12.2 -257.1 27.4 28.7
US
Epizyme Inc
F:EPE
94.1B EUR 1 967.1 -502 -546.6 -532
US
Gilead Sciences Inc
NASDAQ:GILD
103.2B USD 3.7 97.9 9.3 11.8
AU
CSL Ltd
ASX:CSL
143.4B AUD 6.5 36.4 22.3 27.7
US
Seagen Inc
F:SGT
39.3B EUR 18.9 -58.1 -62.5 -56.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
34.6B USD 14.8 -474.5 208.7 321.3
NL
argenx SE
NASDAQ:ARGX
32.4B USD 16.6 -116.8 -93 -67.8
P/E Multiple
Earnings Growth
US
P
Palatin Technologies Inc
LSE:0KF3
Average P/E: 57.3
Negative Multiple: -1 219.7
N/A
US
Abbvie Inc
NYSE:ABBV
65.1
406%
US
Amgen Inc
NASDAQ:AMGN
57.5
74%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29.7
56%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -257.1
38%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502 N/A
US
Gilead Sciences Inc
NASDAQ:GILD
97.9
71%
AU
CSL Ltd
ASX:CSL
36.4
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -474.5 N/A
NL
argenx SE
NASDAQ:ARGX
Negative Multiple: -116.8 N/A
EV/EBITDA Multiple
EBITDA Growth
US
P
Palatin Technologies Inc
LSE:0KF3
Average EV/EBITDA: 47.1
Negative Multiple: -1 236.1
N/A
US
Abbvie Inc
NYSE:ABBV
15.9
28%
US
Amgen Inc
NASDAQ:AMGN
20.1
57%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
26.1
47%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.4
39%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -546.6 N/A
US
Gilead Sciences Inc
NASDAQ:GILD
9.3
10%
AU
CSL Ltd
ASX:CSL
22.3
45%
US
S
Seagen Inc
F:SGT
Negative Multiple: -62.5 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
208.7
N/A
NL
argenx SE
NASDAQ:ARGX
Negative Multiple: -93 N/A
EV/EBIT Multiple
EBIT Growth
US
P
Palatin Technologies Inc
LSE:0KF3
Average EV/EBIT: 68.5
Negative Multiple: -1 223.4
N/A
US
Abbvie Inc
NYSE:ABBV
24.3
86%
US
Amgen Inc
NASDAQ:AMGN
36.5
95%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
28.9
49%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.7
38%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532 N/A
US
Gilead Sciences Inc
NASDAQ:GILD
11.8
26%
AU
CSL Ltd
ASX:CSL
27.7
59%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.4 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
321.3
N/A
NL
argenx SE
NASDAQ:ARGX
Negative Multiple: -67.8 N/A

See Also

Discover More
Back to Top